NovaBay Pharmaceuticals Inc (NBY)
0.7276
+0.02
(+2.12%)
USD |
NYAM |
Nov 14, 16:00
0.7276
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Gross Profit (Annual): 7.895M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.895M |
| December 31, 2022 | 7.781M |
| December 31, 2021 | 6.515M |
| December 31, 2020 | 5.964M |
| December 31, 2019 | 4.861M |
| December 31, 2018 | 11.00M |
| December 31, 2017 | 15.45M |
| December 31, 2016 | 9.433M |
| December 31, 2015 | 3.12M |
| December 31, 2014 | 0.568M |
| December 31, 2013 | 3.315M |
| Date | Value |
|---|---|
| December 31, 2012 | 6.939M |
| December 31, 2011 | 11.02M |
| December 31, 2010 | |
| December 31, 2009 | 15.68M |
| December 31, 2008 | 6.722M |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
4.861M
Minimum
2019
7.895M
Maximum
2023
6.603M
Average
6.515M
Median
2021
Gross Profit (Annual) Benchmarks
| Palatin Technologies Inc | 4.392M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
| Nanoviricides Inc | -- |